Rybelsus
Oral semaglutide pill for diabetes. The only oral GLP-1 currently FDA-approved.
Rybelsus is oral semaglutide 3-14mg daily, FDA-approved for type 2 diabetes. Weight-loss effect exists but smaller than the injectable forms. Useful for needle-averse patients with diabetes; rarely used off-label for weight alone due to weaker effect.